Pharma News

Japan's JCR Pharma licenses gene therapy platform to AstraZeneca Rare Disease unit for $825 M

Japan's JCR Pharmaceuticals Co. has entered into a license agreement with Alexion, AstraZeneca Rare Disease, f

10 July, 2025 | Thursday | News
China's CStone inks deal worth $192.5 M with Istituto Gentili to commercialise cancer drug in Europe

China-based CStone Pharmaceuticals has announced an exclusive partnership with Istituto Gentili, a leading Eur

10 July, 2025 | Thursday | News
Korea's Celltrion announces US launch of denosumab biosimilars for osteoporosis treatment

Celltrion has announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo),

08 July, 2025 | Tuesday | News

BioTech News

Abu Dhabi plans to advance gene therapies for children with Spinal Muscular Atrophy Type 1

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emir

07 July, 2025 | Monday | News
SK bioscience completes expansion of new vaccine production facility in South Korea for global market

SK bioscience, a global innovative vaccine and biotech company based in South Korea, has secured a larg

30 June, 2025 | Monday | News
World's first HLA-G targeted exosome therapy for cancer by Taiwan enters US clinical trials

A research team led by Dr Der-Yang Cho, Superintendent of China Medical University Hospital (Taiwan), in colla

09 June, 2025 | Monday | News

MedTech News

Taiwan advances precision oncology landscape with new bioinformatics platform

Inocras Inc., a global leader in whole-genome sequencing (WGS) and bioinformatics, has announced the signing o

08 July, 2025 | Tuesday | News
Australia's Monash University to design first-of-its-kind CT scanner

Australia's Monash University will lead the design of a first-of-its-kind mobile CT scanner to bring critical

07 July, 2025 | Monday | News

BioServices News

China's WuXi Biologics launches next-generation platform for high-concentration biologics

WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO) in Chi

01 July, 2025 | Tuesday | News
Vetter invests $285 M in new clinical manufacturing site in US

Vetter, a globally operating Contract Development and Manufacturing Organisation (CDMO), recently celebrated t

30 June, 2025 | Monday | News

Inside Magazine

Medical Advances Soar With APAC’S CLINICAL TRIAL GROWTH
It’s a truth universally acknowledged that Asia-Pacific is a hotbed for clinical trials, with multiple reports confirming that it is the only region in the world to have seen a consistent surge in clinical trial activity. The Asia Pacific clinical trials market generated a revenue of $15.91 billion in 2023 and is expected to reach a projected revenue of $25.99 billion by 2030 at a compound annual growth rate of 7.3 per cent, according to the Grand View Research report. Between 2020 and 2025, China, India, Australia, Japan, South Korea, and Singapore emerged as key pillars of Asia-Pacific’s growing clinical trial ecosystem. Together, these six countries accounted for nearly 40,000 trials (39,843 in total). We take a close look at each country’s clinical trial landscape, examining who is leading in which phases, how domestic players compare to multinational sponsors, and which therapeutic areas are seeing the most activity. We also explore the challenges of running trials across such a diverse region.

Click here to access E-magazine

Video Gallery

Events

View All
14 - 17
Jul - 2025

AAPS Summer Scientific Forum 2025

AAPS

membership@aaps.org https://www.aaps.org/ssf

Indianapololis